Clinical trial
NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome
NCT06490926 is registered in ClinicalTrials.gov with Fujian Medical University Union Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome
- Lead sponsor
- Fujian Medical University Union Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 1, 2023
- Completion date
- February 1, 2026
- Enrollment
- 180 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
multiple system atrophy, parkinson's disease, progressive supranuclear palsy